Comments
BioCryst drops hep C drug on safety issues
31.10.2012. | (Reuters) - BioCryst Pharmaceuticals Inc said it would withdraw an application to test its experimental hepatitis C drug in humans after the U.S. Food and Drug Administration expressed concern about its safety....